Printer Friendly

SCHNEIDER'S LASER-WELDED BALLOON CATHETER APPROVED FOR MARKETING BY FDA

SCHNEIDER'S LASER-WELDED BALLOON CATHETER APPROVED FOR MARKETING BY FDA
 NEW YORK, Nov. 3 /PRNewswire/ -- Schneider (USA) Inc, a unit of the Hospital Products Group of Pfizer Inc (NYSE: PFE), said today it has received authorization from the Food and Drug Administration to market the first laser-welded PTCA (Note A) rapid exchange balloon catheter.
 Schneider President Joseph E. Laptewicz Jr. said the balloon catheter, called Mongoose (Note B), is the first ever launched that uses a patent-pending laser welding process developed by Schneider. It features a new, supple distal tip to provide superior trackability as well as a very soft distal catheter section, Mr. Laptewicz said.
 To be demonstrated for the first time at the American Heart Association meeting in New Orleans on Nov. 16, the Mongoose catheter will be available for national distribution within two weeks.
 Submitted to FDA on April 2, 1992, the Mongoose was approved for commercial marketing Oct. 29. U.S. sales of vascular catheters used in angioplasty procedures is estimated at more than $400 million.
 Headquartered in Plymouth, Minn., Schneider (USA) is a leader in advanced angioplasty and angiography products. Pfizer Inc is a diversified, research-based health care company with global operations. Pfizer reported sales of $6.95 billion for 1991.
 (A) -- PTCA is an acronym for Percutaneous Transliminal Coronary Angioplasty.
 (B) -- Mongoose is a registered Pfizer trademark.
 -0- 11/3/92
 /CONTACT: Tony Biesada, 212-573-2055, or Rick Honey, 212-573-2051, both of Pfizer/
 (PFE) CO: Schneider (USA) Inc.; Pfizer Inc ST: Minnesota, New York IN: MTC SU:


GK -- NY055 -- 2154 11/03/92 15:56 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 3, 1992
Words:260
Previous Article:BARRISTER LAUNCHES GROUND-BREAKING SOFTWARE PRODUCT
Next Article:BUTLER INTERNATIONAL, INC. REPORTS IMPROVED OPERATING RESULTS IN THE THIRD QUARTER
Topics:


Related Articles
ADVANCED INTERVENTIONAL SYSTEMS ADDS NEW CATHETER TO CLINICAL TRIALS WITH EXCIMER LASER SYSTEM
CARDIOLOGISTS AT WASHINGTON HOSPITAL CENTER LEAD INVESTIGATION WITH INNOVATIVE LASER CATHETER
TWO NEW CORDIS ANGIOPLASTY CATHETERS GAIN U.S. MARKET RELEASE
SCHNEIDER BEGINS MARKETING PTCA OVER-THE-WIRE BALLOON CATHETER
SCHNEIDER BEGINS MARKETING NEW DIAGNOSTIC CATHETERS
FOUR CORDIS ANGIOPLASTY CATHETERS APPROVED FOR US MARKET RELEASE
SCHNEIDER BEGINS MARKETING BALLOON CATHETER 'FREEHAND'
SCHNEIDER LAUNCHES THREE NEW BALLOON CATHETERS
SCHNEIDER EXPANDS BALLOON CATHETER LINE
ANGIODYNAMICS UNVEILS NEW LINE OF PTA BALLOON CATHETERS.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters